ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1952

Genes Associated with Nucleotide Oligomerization Domain-Like Receptor Signaling Pathway Are Upregulated in Discoid Lupus Erythematosus

Irene Calderon1, Inhan Lee 2 and Rina Mina 3, 1SCDS, Cincinnati, OH, 2mcore, Ann Arbor, MI, 3University of Cincinnati, Cincinnati

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: discoid lupus and innate immunity

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Genetics, Genomics & Proteomics Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Background: Discoid Lupus Erythematosus (DLE) is disfiguring autoimmune skin disorder, associated with defects in the adaptive immune system. The innate immune system is likely involved as seen in the presence of interface dermatitis, observed in viral exanthem, and improvement of DLE using inhibitors to membrane-bound Pattern Recognition Receptors (PRR).

Hypothesis: Genes associated with defects in the innate immune system would be upregulated in DLE skin compared to normal controls.

Methods: Methods: Datasets selected from the Gene Expression Omnibus (GEO), GSE109248, GSE81071, GSE52417, GSE95474, and GSE72535 were analyzed using GEO2R to compare the gene expressions between DLE and normal controls. Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database, Gene Card, and Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway analysis were used to identify the interaction and function of specific genes.

Results: Results: There were a total of 54 DLE skin samples and 37 normal controls. Genes associated with the Nucleotide Oligomerization Domain-Like Receptor (NLR) signaling pathway were consistently differentially expressed in DLE skin samples in all datasets (p-value < 8.74e-05). Five genes associated with the NLR signaling pathway, STAT1, OAS1, OAS2, OAS3, and AIM2, were found to be upregulated in skin samples of DLE patients compared to normal controls in all datasets. These five genes are associated with transcription activation, regulation of viral infection, and interferon response.

Conclusion: Conclusion: Genes associated with the NLR signaling pathway are differentially expressed in the skin of DLE patients compared to normal controls, supporting the role of the innate immune system in DLE. Further validation studies using experimental methods are needed.

Table 1: Gene Functions, Source: Gene-Cards

Image 1: NOD-Like Receptor Genes From GSE 81071


Disclosure: I. Calderon, None; I. Lee, None; R. Mina, None.

To cite this abstract in AMA style:

Calderon I, Lee I, Mina R. Genes Associated with Nucleotide Oligomerization Domain-Like Receptor Signaling Pathway Are Upregulated in Discoid Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/genes-associated-with-nucleotide-oligomerization-domain-like-receptor-signaling-pathway-are-upregulated-in-discoid-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genes-associated-with-nucleotide-oligomerization-domain-like-receptor-signaling-pathway-are-upregulated-in-discoid-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology